Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2010 Second Quarter Earnings
October 05 2009 - 8:00AM
Business Wire
Forest Laboratories, Inc. (NYSE: FRX), an international
manufacturer and marketer of pharmaceutical products, will release
its Fiscal 2010 Second Quarter financial results before the U.S.
stock market opens on Tuesday, October 20, 2009. Later that day, at
10:00 AM EDT, Forest will host a conference call where Dr. Lawrence
Olanoff, President and Chief Operating Officer and Frank Perier,
Senior Vice President-Finance and Chief Financial Officer, will
discuss the financial results and relevant company and industry
topics. The conference call will be webcast live beginning at 10:00
AM ET on the Company's website www.frx.com and also on the website
www.streetevents.com. Please log on to either website at least
fifteen minutes prior to the conference call as it may be necessary
to download software to access the call. A replay of the conference
call will be available until November 4, 2009 at both websites and
also by dialing 1-800-642-1687 (US investors) or +1-706-645-9291
(international investors), Conference Call ID 32976879.
About Forest
Laboratories
Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical
company with a long track record of building partnerships and
developing and marketing products that make a positive difference
in people’s lives. In addition to its well-established franchises
in therapeutic areas of the central nervous and cardiovascular
systems, Forest’s current pipeline includes product candidates in
all stages of development and across a wide range of therapeutic
areas. The company is headquartered in New York, NY. To learn more
about Forest Laboratories, visit www.frx.com.
Except for the historical information contained herein, this
release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. These
statements involve a number of risks and uncertainties, including
the difficulty of predicting FDA approvals, the acceptance and
demand for new pharmaceutical products, the impact of competitive
products and pricing, the timely development and launch of new
products, and the risk factors listed from time to time in Forest
Laboratories’ Annual Report on Form 10-K, Quarterly Report on Form
10-Q, and any subsequent SEC filings.
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Sep 2023 to Sep 2024